Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hypoxia D000860 23 associated lipids
Cystitis D003556 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Cholestasis D002779 23 associated lipids
Birth Weight D001724 23 associated lipids
Fibrosis D005355 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Helicobacter Infections D016481 21 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Brain Edema D001929 20 associated lipids
HIV Infections D015658 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Wounds and Injuries D014947 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Pleurisy D010998 20 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Albuminuria D000419 18 associated lipids
Lymphoma D008223 18 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Bronchial Spasm D001986 18 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Ischemia D007511 18 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Blister D001768 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Neutropenia D009503 15 associated lipids
Encephalitis D004660 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Hemorrhage D006470 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Stomatitis D013280 14 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Heart Arrest D006323 13 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Nasopoulou C et al. Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism. 2011 Lipids Health Dis pmid:22087726
Sánchez FA et al. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. 2011 J. Biol. Chem. pmid:21757745
Dombrowsky H et al. Ingestion of (n-3) fatty acids augments basal and platelet activating factor-induced permeability to dextran in the rat mesenteric vascular bed. 2011 J. Nutr. pmid:21775525
Tsuda M et al. Platelet-activating factor and pain. 2011 Biol. Pharm. Bull. pmid:21804199
Chan MV et al. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. 2011 Platelets pmid:21806492
Zhou X and He P Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca²⁺]i, nitric oxide, and gap formation in intact venules. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21873500
Tsantila N et al. In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. 2011 Angiology pmid:20805097
Zong RK and Liu J [Effects of Chinese herbal medicine Xinfeng Capsule on expressions of platelet-activating factor and interleukins 6 and 17 in peripheral blood of rats with adjuvant arthritis]. 2011 Zhong Xi Yi Jie He Xue Bao pmid:22152774
Smit JJ et al. Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. 2011 PLoS ONE pmid:22194949
Parrill AL et al. Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. 2011 BMC Biochem. pmid:22177013
Ma SG et al. Four new phenolic diglycosides from the roots of Illicium oligandrum. 2011 Carbohydr. Res. pmid:21524732
Yang AP and Chen Q [Correlation between blood-stasis tongue figure and platelet activating factor (PAF) and acetyl hydrolase of PAF (PAF-AH) in patients with primary dysmenorrhea]. 2011 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:21485072
McHowat J et al. Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung. 2011 Am. J. Physiol., Cell Physiol. pmid:21228317
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Brooks AC et al. CXCL8 attenuates chemoattractant-induced equine neutrophil migration. 2011 Vet. Immunol. Immunopathol. pmid:21040981
Greiner C et al. 2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo. 2011 Br. J. Pharmacol. pmid:21506958
Ha SW and Lee CS Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation. 2010 May-Jun Neurochem. Int. pmid:20304020
Michelotto PV et al. Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. 2010 Mar-Apr J. Vet. Intern. Med. pmid:20102491
Ploppa A et al. Local anesthetic effects on human neutrophil priming and activation. 2010 Jan-Feb Reg Anesth Pain Med pmid:20048657
Ciprandi G and Cirillo I Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. 2010 Apr-Jun J. Biol. Regul. Homeost. Agents pmid:20487631
Church MK Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. 2010 Br. J. Dermatol. pmid:20819087
Hasan AM et al. Phosphoinositide 3-kinase gamma mediates chemotactic responses of human eosinophils to platelet-activating factor. 2010 Int. Immunopharmacol. pmid:20685403
Zhao W et al. [Expression and regulation of pituitary adenylate cyclase-activating polypeptide mRNA in pregnant rat corpus luteum]. 2010 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21038678
Asaka N et al. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. 2010 Arzneimittelforschung pmid:21117500
Kordan W et al. Effect of platelet activating factor (PAF) supplementation in semen extender on viability and ATP content of cryopreserved canine spermatozoa. 2010 Pol J Vet Sci pmid:21370733
Gao F et al. [The levels of platelet-activating factor and nitric oxide synthase in bronchial asthma at high altitude]. 2010 Zhonghua Jie He He Hu Xi Za Zhi pmid:20979844
Xu CL et al. [Inhibitory effect of TBN on platelet aggregation in rabbit]. 2010 Zhong Yao Cai pmid:21243778
Chen S et al. [Induction effect of platelet-activating factor on Src-suppressed C kinase substrate gene expression in rat pulmonary microvascular endothelial cells]. 2010 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:20367900
Leoni G et al. The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. 2010 Br. J. Pharmacol. pmid:20331604
Danker K et al. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane. 2010 Br. J. Pharmacol. pmid:20331609
Kajiwara N et al. Activation of human mast cells through the platelet-activating factor receptor. 2010 J. Allergy Clin. Immunol. pmid:20392487
Corl CM et al. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge. 2010 Vet. Immunol. Immunopathol. pmid:20359754
Shi C et al. H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761. 2010 Neurochem. Int. pmid:20362023
Coy B ED et al. The first diastereoselective synthesis of cinerins A-C, PAF-antagonistic macrophyllin-type bicyclo[3.2.1]octane neolignans, using a novel Pd-catalysed oxyarylation. 2010 Org. Biomol. Chem. pmid:20401372
Ritter JM Novel targets and regulatory ordeal by QT interval. 2010 Br J Clin Pharmacol pmid:20406216
Donado E et al. No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. 2010 Br J Clin Pharmacol pmid:20406224
Rieder F et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20299604
Prokosch V et al. Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20592227
Morimoto R et al. Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages. 2010 J. Biol. Chem. pmid:20663880
Balestrieri ML et al. Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. 2010 Biochim. Biophys. Acta pmid:20637897
Karasuyama H et al. Role for basophils in systemic anaphylaxis. 2010 Chem Immunol Allergy pmid:20519883
Sanz ML et al. In vitro diagnosis of anaphylaxis. 2010 Chem Immunol Allergy pmid:20519886
Sharma J et al. Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse. 2010 Biochemistry pmid:20521843
Cerkiene Z et al. Immune factors in human embryo culture and their significance. 2010 Medicina (Kaunas) pmid:20571290
Adamson RH et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. 2010 Cardiovasc. Res. pmid:20542878
Liu SH et al. Protection of carbon monoxide intraperitoneal administration from rat intestine injury induced by lipopolysaccharide. 2010 Chin. Med. J. pmid:20497711
Kuebler WM et al. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. 2010 Cell. Physiol. Biochem. pmid:20502002
Wang L et al. Three new compounds from Morus nigra L. 2010 J Asian Nat Prod Res pmid:20552479
Shin SH et al. Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells. 2010 Cell. Physiol. Biochem. pmid:21063106
Grassi G et al. Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. 2010 J. Endocrinol. Invest. pmid:20220291